Back to Journals » Biologics: Targets and Therapy » Volume 12
Review
Two decades with omalizumab: what we still have to learn
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
19,230 | Dovepress* | 14,786+ | 1,532 | 16,318 | |
PubMed Central* | 4,444 | 883 | 5,327 | ||
Totals | 19,230 | 2,415 | 21,645 | ||
*Since 26 October 2018 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
8 | 0 | 0 | 0 | 3 | 5 |
View citations on PubMed Central and Google Scholar